Journal
Clinical and Experimental Medicine
Publication Date
5-1-2022
Volume
22
Issue
2
First Page
209
Last Page
220
Document Type
Open Access Publication
DOI
10.1007/s10238-021-00745-5
Rights and Permissions
Wilfong EM, Vowell KN, Bunn KE, Rizzi E, Annapureddy N, Dudenhofer RB, Barnado A, Bonami RH, Johnson JE, Crofford LJ, Kendall PL. CD19 + CD21lo/neg cells are increased in systemic sclerosis-associated interstitial lung disease. Clin Exp Med. 2022 May;22(2):209-220. doi: 10.1007/s10238-021-00745-5. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Recommended Citation
Wilfong, Erin M; Vowell, Katherine N; Bunn, Kaitlyn E; Rizzi, Elise; Annapureddy, Narender; Dudenhofer, Rosemarie B; Barnado, April; Bonami, Rachel H; Johnson, Joyce E; Crofford, Leslie J; and Kendall, Peggy L, "CD19 + CD21lo/neg cells are increased in systemic sclerosis-associated interstitial lung disease." Clinical and Experimental Medicine. 22, 2. 209 - 220. (2022).
https://digitalcommons.wustl.edu/oa_4/3036
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
